Escherichia coli ID 12-18 is a mesophilic human pathogen that has multiple antibiotic resistances and was isolated from Tracheal secretion.
antibiotic resistance mesophilic human pathogen| @ref 20215 |
Last LPSN update
2026-02-09 11:18:50 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Enterobacteriaceae |
| Genus Escherichia |
| Species Escherichia coli |
| Full scientific name Escherichia coli (Migula 1895) Castellani and Chalmers 1919 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 18136 | LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) | Medium recipe at MediaDive  | Name: LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) Composition: Agar 20.0 g/l NaCl 10.0 g/l Tryptone 10.0 g/l Yeast extract 5.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 18136 | positive | growth | 37 | mesophilic |
| Test 1 | |
|---|---|
| @ref | 18136 |
| Medium | Mueller-Hinton Agar |
| Manual annotation | 1 |
| Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 18 |
| Ampicillin 10µg (disc) | 0 |
| Aztreonam 30µg (disc) | 10 |
| Bacitracin 10Unit | 0 |
| Cefalotin 30µg (disc) | 0 |
| Cefazolin 30µg (disc) | 0 |
| Cefotaxime 30µg (disc) | 8 |
| Ceftriaxone 30µg (disc) | 6-8 |
| Chloramphenicol 30µg (disc) | 30 |
| Clindamycin 10µg (disc) | 0 |
| Colistin 10µg (disc) | 14 |
| Doxycycline 30µg (disc) | 22 |
| Erythromycin 15µg (disc) | 0 |
| Fosfomycin 50µg (disc) | 16-18 |
| Gentamycin 10µg (disc) | |
| Imipenem 10µg (disc) | 32 |
| Kanamycin 30µg (disc) | 10 |
| Lincomycin 15µg (disc) | 0 |
| Linezolid 10µg (disc) | 0 |
| Mezlocillin 30µg (disc) | 0 |
| Moxifloxacin 5µg (disc) | 0 |
| Neomycin 30µg (disc) | 20 |
| Nitrofurantoin 100µg (disc) | 22 |
| Norfloxacin 10µg (disc) | 0 |
| Nystatin 100Unit | 0 |
| Ofloxacin 5µg (disc) | 0 |
| Oxacillin 5µg (disc) | 0 |
| Penicillin G 6µg (disc) | 0 |
| Pipemidic acid 20µg (disc) | 0 |
| Piperacillin/Tazobactam 40µg (disc) | 22 |
| Polymyxin B 300Unit | 16 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 |
| Teicoplanin 30µg (disc) | 0 |
| Tetracycline 30µg (disc) | 28 |
| Ticarcillin 75µg (disc) | 0 |
| Vancomycin 30µg (disc) | 0 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68368 | 27613 ChEBI | amygdalin | - | fermentation | from API 20E |
| 68368 | 16947 ChEBI | citrate | - | assimilation | from API 20E |
| 68368 | 17634 ChEBI | D-glucose | + | fermentation | from API 20E |
| 68368 | 16899 ChEBI | D-mannitol | + | fermentation | from API 20E |
| 68368 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20E |
| 68368 | 30849 ChEBI | L-arabinose | + | fermentation | from API 20E |
| 68368 | 62345 ChEBI | L-rhamnose | + | fermentation | from API 20E |
| 68368 | 17268 ChEBI | myo-inositol | - | fermentation | from API 20E |
| 68368 | 18257 ChEBI | ornithine | + | degradation | from API 20E |
| 68368 | 30911 ChEBI | sorbitol | + | fermentation | from API 20E |
| 68368 | 17992 ChEBI | sucrose | + | fermentation | from API 20E |
| 68368 | 27897 ChEBI | tryptophan | + | energy source | from API 20E |
| 68368 | 16199 ChEBI | urea | - | hydrolysis | from API 20E |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 18136 | 28971 | Ampicillin | 10 µg (disc) | from Antibiotic test | |
| 18136 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 18136 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 18136 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 18136 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 18136 | 48923 | Erythromycin | 15 µg (disc) | from Antibiotic test | |
| 18136 | 17833 | Gentamycin | 10 µg (disc) | from Antibiotic test | |
| 18136 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 18136 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 18136 | 6919 | Mezlocillin | 30 µg (disc) | from Antibiotic test | |
| 18136 | 63611 | Moxifloxacin | 5 µg (disc) | from Antibiotic test | |
| 18136 | 100246 | Norfloxacin | 10 µg (disc) | from Antibiotic test | |
| 18136 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 18136 | 7731 | Ofloxacin | 5 µg (disc) | from Antibiotic test | |
| 18136 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 18136 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 18136 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 18136 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 18136 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 18136 | 9587 | Ticarcillin | 75 µg (disc) | from Antibiotic test | |
| 18136 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
| @ref | ONPG | ADH (Arg) | LDC (Lys) | ODC | CIT | H2S productionH2S | URE | TDA (Trp) | IND | Acetoin production (Voges Proskauer test)VP | GEL | GLU | MAN | INO | Sor | RHA | SAC | MEL | AMY | ARA | OX | Nitrite productionNO2 | Reduction to N2N2 | MotilityMOB | Growth on MacConkey mediumMAC | OF-O | OF-F | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18136 | + | - | +/- | + | - | - | - | - | + | - | - | + | + | - | + | + | + | - | - | + | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | |
| 18136 | + | + | + | + | - | - | - | - | + | - | - | + | + | - | + | + | + | + | - | + | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Phylogeny | GC-IMS headspace analyses allow early recognition of bacterial growth and rapid pathogen differentiation in standard blood cultures. | Drees C, Vautz W, Liedtke S, Rosin C, Althoff K, Lippmann M, Zimmermann S, Legler TJ, Yildiz D, Perl T, Kunze-Szikszay N. | Appl Microbiol Biotechnol | 10.1007/s00253-019-10181-x | 2019 | |
| Blood Culture Headspace Gas Analysis Enables Early Detection of Escherichia coli Bacteremia in an Animal Model of Sepsis. | Euler M, Perl T, Eickel I, Dudakova A, Maguilla Rosado E, Drees C, Vautz W, Wieditz J, Meissner K, Kunze-Szikszay N. | Antibiotics (Basel) | 10.3390/antibiotics11080992 | 2022 | | |
| Modern approaches for detection of volatile organic compounds in metabolic studies focusing on pathogenic bacteria: Current state of the art. | Zuchowska K, Filipiak W. | J Pharm Anal | 10.1016/j.jpha.2023.11.005 | 2024 | | |
| Phylogeny | Detection and validation of volatile metabolic patterns over different strains of two human pathogenic bacteria during their growth in a complex medium using multi-capillary column-ion mobility spectrometry (MCC-IMS). | Kunze N, Gopel J, Kuhns M, Junger M, Quintel M, Perl T. | Appl Microbiol Biotechnol | 10.1007/s00253-013-4762-8 | 2013 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive4926.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License